How should doctors handle end-of-life care or use new medical innovations like genetic technologies? How can they ensure they’re fairly and equally providing healthcare? How can providers build trust with patients?

These are just a few of the big questions medical ethicists study and advise on. Richard Sharp, a professor of biomedical ethics at Rochester, Minnesota-based Mayo Clinic, is one of these professionals. For decades, he has been a bridge between patients and providers as well as advocates and innovators to ensure medical practices are safe and fair.

“As an academic discipline, biomedical ethics is the study of moral issues that arise in the context of healthcare and in the context of scientific research,” Sharp told Healthcare Brew. “But biomedical ethics as an activity is really about giving patients a voice and helping their perspectives to be heard by scientists and physicians, and to influence the care that they receive.”

Sharp took Healthcare Brew through a day in his life at Mayo Clinic, which he said has over 20 medical ethicists on staff. If you find yourself thinking it sounds like he has a lot on his plate, you would be correct!

Keep reading here about what Sharp’s workdays look like. —CM

The FDA receives more than 2 million reports of deaths, injuries, and malfunctions thought to be associated with medical devices every year.

Some of these suspicions are serious enough for the agency to issue an official recall. Recalls, which are typically voluntary, are not all the same. They can refer to pulling a device from the market, or modifying an existing product to improve its safety. These recalls are labeled from Class III (least dangerous) to Class I (most dangerous).

It’s crucial for nurses, doctors, and healthcare executives to keep track of recalls. That’s where we come in!

Get the download on June’s FDA recalls here.—CC

It’s been quite a year for pharmaceutical development, full of twists, turns, and new treatments.

Were you too busy to follow along? Honestly, we don’t blame you.

To help you out, we’re breaking down three interesting and potentially market-defining treatments that emerged this year, zooming in on how they work and how they may impact the pharmaceuticals market.

Let’s get into the details here.—CC

Learn what nurses from California and North Carolina had to say about why
they’re concerned about AI and what they’re doing to prevent harm.

Real jobs, shared through real communities. CollabWORK brings opportunities directly to Healthcare Brew readers—no mass postings, no clutter, just roles worth seeing. Click here to view the full job board.